AIATELLA Oy

AIATELLA Oy is a Finnish health-technology company founded in 2022 and headquartered in Helsinki. It develops artificial-intelligence software for cardiovascular imaging and screening, with the stated goal of transforming cardiovascular workflows so that clinicians can obtain faster, more precise analyses and detect disease earlier. The company frames its mission around a global healthcare crisis: imaging volumes are rising while specialist expertise remains scarce, particularly in settings without on-site cardiovascular imaging specialists. AIATELLA's product direction is centred on automating complex cardiovascular image analysis and delivering instant, precise measurements that reduce time to diagnosis. The company says its AI analysis at the point of care can widen access to early detection and prevention, and can provide specialist-level insights even where on-site expertise is unavailable. Its public messaging positions the technology as a way to remove barriers to early cardiovascular disease detection, allowing healthcare providers to intervene sooner and patients to access life-saving care before it is too late. The leadership team combines biomedical, engineering and clinical expertise. Jack Parker, CEO and co-founder, co-founded the company to apply his biomedical knowledge and understanding of UK healthcare to the global challenge of cardiovascular disease. Onni Eriksson, CTO and co-founder, focuses on translating clinical challenges into technological solutions, with societal impact as a stated mission. Dr. Jari Salo serves as CIO and is described as an orthopedic and trauma specialist with expertise in medical imaging and the application of artificial intelligence to diagnostic processes. The company also works with medical advisors, including Scott Flamm, previously Head of Cardiovascular Imaging at Cleveland Clinic from 2006 to 2023. AIATELLA operates in the medical AI and cardiovascular diagnostics space, a field that includes imaging software vendors, hospital workflow tools and specialist AI analysis platforms. Its website invites prospective users to join a waitlist and to explore its solutions, indicating an early-stage commercialisation phase rather than a fully scaled global rollout. The company is privately held and, as of the available evidence, does not disclose a parent company or public listing. Its Finnish registration and Helsinki base place it within Finland's growing health-technology ecosystem, while its leadership's UK healthcare background suggests a dual orientation toward Nordic and UK markets.

AIATELLA Oy was founded in 2022 to transform cardiovascular care. According to the company, it was established in response to a global healthcare crisis: cardiovascular imaging volumes are increasing while specialist expertise is in short supply. The founding team chose to address this gap through AI-powered automation rather than through conventional imaging hardware or manual analysis alone. The company is headquartered in Helsinki, Finland, and is registered as AIATELLA Oy, the Finnish limited-liability company form. Its leadership combines biomedical, engineering and clinical backgrounds. Jack Parker, CEO and co-founder, brought biomedical knowledge and an understanding of UK healthcare to the venture; Onni Eriksson, CTO and co-founder, focused on converting clinical challenges into technological solutions. Dr. Jari Salo, CIO, is an orthopedic and trauma specialist with expertise in medical imaging and the application of artificial intelligence to diagnostic processes. The company also draws on external medical advisors, including Scott Flamm, who served as Head of Cardiovascular Imaging at Cleveland Clinic from 2006 to 2023. AIATELLA's public positioning centres on automating complex cardiovascular image analysis and delivering instant, precise measurements that reduce time to diagnosis. The company states that its AI analysis at the point of care can widen access to early detection and prevention and can provide specialist-level insights even in settings without on-site expertise. Its website describes a vision of removing barriers to early cardiovascular disease detection so that healthcare providers can intervene sooner and patients can access life-saving care before it is too late. As of the available evidence, AIATELLA remains privately held and does not disclose a parent company or public listing. Its website invites visitors to join a waitlist and to explore its solutions, suggesting an early-stage commercialisation phase. The company operates in the medical AI and cardiovascular diagnostics sector, where it competes with imaging software vendors, hospital workflow providers and specialist AI analysis platforms. Its Finnish base places it within Finland's health-technology ecosystem, while the UK healthcare background of its CEO points to a cross-border orientation toward Nordic and UK markets.

• 2022

  AIATELLA Oy founded to transform cardiovascular care through AI-powered automation.

• 2006

  Scott Flamm begins tenure as Head of Cardiovascular Imaging at Cleveland Clinic (to 2023); later becomes AIATELLA medical advisor.

AI-powered automation for cardiovascular imaging that improves speed, accuracy and precision of diagnostics and widens access to early detection, including in settings without on-site specialist expertise.

• AI cardiovascular imaging and screening platform

  Software that automates complex cardiovascular image analysis, delivers instant precise measurements, reduces time to diagnosis, and supports point-of-care early detection and prevention.

1. 1AI Cardiovascular Imaging & Screening | AIATELLAaiatella.com
2. 2About AIATELLA — Our Story, Team & Missionaiatella.com
3. 3AIATELLA Oy (Finland) — Wikidatawikidata.org